Personal information

No personal information available

Activities

Collapse all

Works (21)

Data from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.c.7478415
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Figure 1 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160842
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Figure 2 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160839
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Figure 3 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160836
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Figure S1 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160833
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Figure S2 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160830
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Figure S3 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160827
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Figure S4 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160824
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Figure S5 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160821
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Figure S6 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160818
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Figure S7 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160815
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Figure S8 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160812
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Supplemental Figure Legends from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160809
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Supplemental Table 1 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160806
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Supplemental Table 2 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160803
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Supplemental Table 3 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160800
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Supplemental Table 4 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160797
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Supplemental Table 5 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160794
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Supplemental Table 6 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160791
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Table 1 from Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

2024-10-03 | Preprint
DOI: 10.1158/2767-9764.27160788
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref

Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis

Cancer Research Communications
2024-10-01 | Journal article
DOI: 10.1158/2767-9764.CRC-24-0250
Contributors: Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S. Diamond; Jacob Aptekar; Theodore B. Moore; Esther H. Nie; Mark R. Hanudel; Theodore S. Nowicki
Source: check_circle
Crossref
How many people are using ORCID?